DSDamayanti Rusli Sjarif

Damayanti Rusli Sjarif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Damayanti Rusli Sjarif has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bidasari Lubis

    Pediatric Hematology–Oncology Division, Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

    1 shared publication
  • Cut Nurul Hafifah

    Nutrition and Metabolic Diseases Division, Department of Pediatrics, Faculty of Medicine, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia

    1 shared publication
  • Erna Simanjuntak

    Regional Health Laboratory, Jakarta, Indonesia

    1 shared publication
  • Ferry Liwang

    Pediatric Resident, Department of Child Health, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

    1 shared publication
  • Fitri Primacakti Wiharta

    Pediatric Hematology–Oncology Division, Department of Child Health, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia

    1 shared publication
  • I. Gusti L. Sidiartha

    Department of Child Health, Faculty of Medicine, University of Udayana, Sanglah Hospital, Denpasar, Indonesia

    1 shared publication

Latest Publications

  • Profile of human milk oligosaccharides and maternal FUT2 polymorphism: genotype-phenotype correlation and proposed cut-off for secretor status

    by Klara Yuliarti, Sander Sebastian van Leeuwen, Muchtaruddin Mansyur, Ina S. Timan, Yulia Ariani, I. Gusti L. Sidiartha, Erna Simanjuntak, Damayanti Rusli Sjarif

    Background Human milk oligosaccharides (HMO) are complex carbohydrates which is undigestible to humans and confer health benefits. The synthesis of HMOs is determined by fucosyltransferase enzymes, which are encoded by FUT2/FUT3 genes. Polymorphisms of the FUT2 result in various secretor status. This study aimed to identify the proportion of secretor and FUT2 genotype-phenotype correlation in Indonesian mothers. Methods This was a cross-sectional study, recruiting 120 healthy mothers aged at least 18 years who exclusively breastfed. Breastmilk samples were obtained at infant’s age 2–5 weeks old. Analysis of HMO was performed using Ultra High-Performance Liquid Chromatography-Fluorescence Detection. Sequencing of entire coding region was performed to find genetic variants of FUT2. The ROC analysis was done to determine the threshold value of 2’FL based on FUT2 genotype. Results The proportion of secretor was 65.8%. A novel FUT2 variant was identified, c.851C>G. There was a significant association between secretor genotype and phenotype (p < 0.001). A threshold value of 425.9 mg/L for 2’FL was obtained, with 98.7% sensitivity and 100% specificity. Conclusion Proportion of secretor in Indonesian is lower than of Caucasian. The widely used 2’FL cut-off at 25–50 mg/L needs to be re-evaluated based on clinical health impact or genotype findings. Impact This study answered the question of secretor proportion in Indonesian mothers (65.8%). The significant differences among countries implied that the consequences of secretor status to infant’s health should be elaborated, including the contribution of less common HMOs. We demonstrated a strong correlation between FUT2 genotype-phenotype and discovered a novel FUT2 variant, c.851C>G. This study obtained a secretor cut-off at 2’FL 425 mg/L based on ROC curve for FUT2 genotype and 2’FL values. This cut-off needs to be evaluated in light of clinical impact, ideally in a longitudinal study design to capture dynamic of human milk across lactation period.

  • Open Access

    Association between Musculoskeletal Status and Genetic Mutations in Patients with Hemophilia A

    by Fitri Primacakti, Pustika Amalia Wahidiyat, Damayanti R. Sjarif, Novie Amelia Chozie, Naura Anindya Candini, Joedo Prihartono, Ninik Sukartini, Nadhifa Tazkia Ramadhani, Bidasari Lubis

    Introduction: Hemophilia A is an inherited bleeding disorder caused by mutations in the factor VIII (FVIII) gene. These mutations result in either reduced FVIII synthesis (null variants) or loss of FVIII function (non-null variants). Null variants are typically associated with more severe FVIII deficiency and recurrent joint bleeding, which may adversely affect musculoskeletal health. Objective: To evaluate the relationship between musculoskeletal status and genetic mutations in patients with hemophilia A. Methods: A cross-sectional study was conducted at the Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo Hospital from June 2024 to March 2025. Genetic analysis was performed at the Human Genetic Research Center using inverse-shifting PCR and Sanger sequencing. Mutations were classified as null variants (intron-22 inversion, intron-1 inversion, large deletion, and nonsense mutations) and non-null variants (missense and non-conserved splice mutation). Musculoskeletal status was assessed by the presence of target joints and the Hemophilia Joint Health Score (HJHS), which evaluates global gait and joint function of the elbows, knees, and ankles. Higher HJHS scores indicate worse joint health. Results: Sixty patients were included in this study, of which 39 had severe, 15 had moderate, and the remaining 6 had mild hemophilia A. The median age was 9.5 years (range 2-18). Null variants were identified in 45/60 patients and non-null variants in 15/60 patients. The most common target joints were the knees in patients with null variants and the ankles in those with non-null variants. The median HJHS was 4 (Q1-Q3: 2-13.5) in the null variant group and 2 (Q1-Q3: 1-11) in the non-null variant group. No significant association was observed between the target joint and the HJHS and genetic mutations. Further subgroup analysis showed no difference in HJHS between mutation groups among patients receiving prophylaxis (p=0.366) or on-demand treatment (p=0.458). Conclusion: No association was found between genetic mutation type and musculoskeletal status in patients with Hemophilia A. HJHS did not differ between mutation groups regardless of treatment regimens.

  • Open Access

    Gastrointestinal Tolerance and Refeeding Syndrome in Severely Malnourished Children Treated with Oral Nutrition Supplements Compared to F-75/F-100: A Hospital-Based Randomized Controlled Pilot Trial

    by Klara Yuliarti, Lanny Christine Gultom, Cut Nurul Hafifah, Ina Susianti Timan, Merci Monica Boru Pasaribu, Ferry Liwang, Valensia Vivian The, Damayanti Rusli Sjarif

    Yuliarti K, et al. Pediatr Gastroenterol Hepatol Nutr. 2026 Mar;29(2):169-182. https://doi.org/10.5223/pghn.2026.29.2.169